Potential of Host Markers Produced by Infection Phase-dependent Antigen-stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area
Overview
Authors
Affiliations
Background: Recent interferon gamma (IFN-γ)-based studies have identified novel Mycobacterium tuberculosis (M.tb) infection phase-dependent antigens as diagnostic candidates. In this study, the levels of 11 host markers other than IFN-γ, were evaluated in whole blood culture supernatants after stimulation with M.tb infection phase-dependent antigens, for the diagnosis of TB disease.
Methodology And Principal Findings: Five M.tb infection phase-dependent antigens, comprising of three DosR-regulon-encoded proteins (Rv2032, Rv0081, Rv1737c), and two resucitation promoting factors (Rv0867c and Rv2389c), were evaluated in a case-control study with 15 pulmonary TB patients and 15 household contacts that were recruited from a high TB incidence setting in Cape Town, South Africa. After a 7-day whole blood culture, supernatants were harvested and the levels of the host markers evaluated using the Luminex platform. Multiple antigen-specific host markers were identified with promising diagnostic potential. Rv0081-specific levels of IL-12(p40), IP-10, IL-10 and TNF-α were the most promising diagnostic candidates, each ascertaining TB disease with an accuracy of 100%, 95% confidence interval for the area under the receiver operating characteristics plots, (1.0 to 1.0).
Conclusions: Multiple cytokines other than IFN-γ in whole blood culture supernatants after stimulation with M.tb infection phase-dependent antigens show promise as diagnostic markers for active TB. These preliminary findings should be verified in well-designed diagnostic studies employing short-term culture assays.
Wang J, Jiang F, Cheng P, Ye Z, Li L, Yang L Mol Biomed. 2024; 5(1):15.
PMID: 38679629 PMC: 11056354. DOI: 10.1186/s43556-024-00177-z.
Baatjies L, van Rensberg I, Snyders C, Gutschmidt A, Loxton A, Williams M PLoS One. 2023; 18(6):e0286965.
PMID: 37319185 PMC: 10270350. DOI: 10.1371/journal.pone.0286965.
Vivekanandan M, Adankwah E, Aniagyei W, Acheampong I, Minadzi D, Yeboah A Infection. 2023; 51(4):1013-1023.
PMID: 36650358 PMC: 10352402. DOI: 10.1007/s15010-023-01977-1.
Cheng P, Wang L, Gong W Front Microbiol. 2022; 13:947852.
PMID: 35836423 PMC: 9273951. DOI: 10.3389/fmicb.2022.947852.
Mao L, Xu L, Wang X, Du J, Sun Q, Shi Z Eur J Clin Microbiol Infect Dis. 2022; 41(7):1039-1049.
PMID: 35612766 DOI: 10.1007/s10096-022-04459-8.